BioWorld

Jan. 8, 2002

View Archived Issues

Chiron Buying Matrix For $61M, Adding Tezacitabine To Pipeline

Chiron Corp., its eyes firmly focused on the cancer therapeutic tezacitabine, is acquiring Matrix Pharmaceutical Inc. for $61 million in cash. Read More

Alexion Starts Phase III Study With Heart Drug Pexelizumab

Read More

Rodents Modeling Parkinson s Disease Generate Dopaminergic Neurons To Stem Losses In PD

Read More

Tripos Collaborates With Pfizer To Help Build Compound Library

Read More

Other News To Note

Read More

Structural GenomiX Partners With Millennium, Aventis For Discovery

Read More

Alteon Raising $18.6M To Fund Discovery, Development Work

Read More

Genencor, Seattle Genetics Align To Develop Cancer Therapeutics

Read More

Appointments And Advancements

Read More